Target
Tyrosine-protein kinase BTK
Ligand
BDBM278938
Substrate
n/a
Meas. Tech.
Btk Enzyme Activity Assay
IC50
0.700±n/a nM
Citation
 Liu, JKozlowski, JAGao, XGuiadeen, DGLiu, SWang, D Substituted imidazo[1,5-a]pyrazines as Btk inhibitors US Patent  US10040805 Publication Date 8/7/2018 
Target
Name:
Tyrosine-protein kinase BTK
Synonyms:
AGMX1 | ATK | Agammaglobulinaemia tyrosine kinase | Agammaglobulinemia tyrosine kinase | B cell progenitor kinase | B-cell progenitor kinase | BPK | BTK | BTK_HUMAN | Bruton tyrosine kinase | Tyrosine Kinase BTK | Tyrosine-protein kinase (BTK) | Tyrosine-protein kinase BTK (BTK)
Type:
Enzyme
Mol. Mass.:
76289.95
Organism:
Homo sapiens (Human)
Description:
Q06187
Residue:
659
Sequence:
MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES
  
Inhibitor
Name:
BDBM278938
Synonyms:
4-{8-amino-3- [(6R,8aS)-6-methyl-3- oxohexahydro[1,3] oxazolo[3,4-a]pyridin- 6-yl]imidazo[1,5-a] pyrazin-1-yl}-3- ethoxy-N-[1-methyl- 5-(trifluoromethyl)- 1H-pyrazol-3- yl]benzamide | US10040805, Example 8
Type:
Small organic molecule
Emp. Form.:
C28H29F3N8O4
Mol. Mass.:
598.5763
SMILES:
CCOc1cc(ccc1-c1nc(n2ccnc(N)c12)[C@]1(C)CC[C@H]2COC(=O)N2C1)C(=O)Nc1cc(n(C)n1)C(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: